The CD2AP gene helps cells keep their shape and stay attached, especially in the kidney’s filtering units. When it does not work properly, those filters can become leaky, which may cause protein to spill into the urine and can lead to some forms of kidney disease. This gene plays an important role in brain and immune cell function as well. Some CD2AP variants are also linked to Alzheimer disease risk, but they do not make the condition certain.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or managing activities in the body. Some genes carry the information needed to make proteins, the parts of cells that do the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
CD2APGene function
What if the gene works
The CD2AP gene helps cells keep their shape and stay connected. It is especially important in kidney filtering cells, where it supports the filter barrier and helps move proteins inside cells.
Risk
What if the gene does not work
Some variants in the CD2AP gene can impair the kidney’s filtering cells, leading to protein loss in urine and focal segmental glomerulosclerosis, a condition that may progress to kidney failure. Effects can range from milder to more severe.
Treatment
What does that mean for your treatment
No CD2AP-specific treatment or management approach is currently established for people with a pathogenic variant in the CD2AP gene. In research, the CD2AP gene is being studied mainly as a marker of kidney cell injury and as a risk related gene in Alzheimer disease, rather than as a current drug target used in routine care.
Conditions associated with CD2AP
Gene function
What if the gene works
Inside your cells, the CD2AP gene helps organize proteins at the cell surface and just beneath it. This support keeps cell edges stable, helps neighboring cells stay connected, and helps cells move selected surface proteins inward for reuse or removal. Understanding how the CD2AP gene works helps explain how your cells manage everyday structure and communication.
CD2AP helps anchor surface proteins to the actin framework, the inner support mesh that gives cells shape. This helps cell edges stay organized during normal movement and daily wear.
It helps gather proteins where one cell meets another. This supports firm, flexible attachments so tissues can hold together.
CD2AP helps cells pull selected surface proteins inward in small packets for sorting, reuse, or removal. This cell surface protein recycling helps keep signaling and nutrient handling balanced.
It acts like a coordinator, bringing several proteins together at the cell membrane so messages can be passed along in an orderly way. This helps cells respond to routine cues from their surroundings.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more substantially change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CD2AP gene can weaken or shorten the CD2AP protein, so it is less able to keep key protein groups connected inside cells. Some CD2AP gene variants have mild effects, while more disruptive variants can greatly reduce protein stability or remove important regions needed to interact with other proteins. In kidney filter cells, bigger functional changes may be linked to earlier or more marked problems.
How variants are linked to conditions
Rare, disease-causing variants in the CD2AP gene can cause steroid-resistant nephrotic syndrome, often with focal segmental glomerulosclerosis, making the CD2AP gene and kidney disease link the clearest established association. Common variants in or near the CD2AP gene have also been linked to a small increase in late-onset Alzheimer disease risk, but many people who carry them never develop dementia.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are widely seen across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In other situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the CD2AP gene itself. Some CD2AP changes have been linked with conditions such as kidney disease or a higher chance of Alzheimer’s disease, but overall risk still depends on the exact gene change, family history, age, and other health factors.
Inheritance of CD2AP variants
There is not yet a single, broadly confirmed disease specific inheritance pattern for the CD2AP gene that applies across all CD2AP related findings, because many reported changes are discussed as risk factors or are still being studied. In practical terms, CD2AP gene inheritance follows the usual pattern for a gene on an autosome when the gene itself is passed on through families. The CD2AP gene is located on chromosome 6, so each person inherits one copy from each parent.
What does my CD2AP result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for CD2AP, and the effect of a CD2AP result on relatives can depend a lot on the exact variant and the health problem involved. If you have a specific CD2AP finding and want to understand what it could mean for family members, a doctor or genetic counselor can help explain it in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the CD2AP gene usually reads the DNA sequence from a blood sample, saliva sample, or cheek swab. The result may identify a variant and classify it as benign, uncertain, or linked to disease, based on current medical evidence.
When should I consider getting a genetic test?
A genetic test that includes the CD2AP gene may be considered if you or your child has signs of an inherited kidney condition, such as heavy protein leaking into the urine, nephrotic syndrome, or a family history of early kidney failure. CD2AP is usually checked as part of a kidney gene panel rather than on its own.
A genetic result is only one part of your health story
A genetic result can be informative, but what it can tell you varies depending on the condition and the kind of variant involved. Over time, many factors influence how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put a person’s experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can affect the way a person responds to medication. By examining links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can help support treatment decisions that are more informed and more individualized. If you want to read more about this subject, more information is available in the LearnHub.
Drugs influenced by the CD2AP gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding how medicines are chosen or used at this time, so questions about side effects, treatment response, or medicine safety are best discussed with your doctor.
History
CD2AP entered the scientific literature in the late 1990s, when researchers identified it while studying how immune cells organize signals at their surface. It was first named for its link to the CD2 protein, which is how the gene got its current name. From these first observations, research expanded steadily. Scientists then recognized that changes in the CD2AP gene could also be relevant in kidney disease, especially in families affected by focal segmental glomerulosclerosis. In the years that followed, studies connected the gene to broader areas of human health, including brain aging and Alzheimer disease risk. This gradual shift turned CD2AP from a narrowly studied gene into one with wider clinical interest.